Back to: MDS 2023
MD Education Ltd
4/4a Bloomsbury Square, London , WC1A 2RP
MD Education USA LLC,
4600 140th Avenue North, Suite 180, Clearwater, Florida 33762
Developed by Unet
Moffitt Cancer Center, Tampa, Florida, USA
David Sallman, MD, is an Assistant Member in the Department of Malignant Hematology at Moffitt Cancer Center in Tampa, FL. His clinical interests are myelodysplastic syndromes (MDS), acute myeloid leukemia (AML), and myeloproliferative neoplasms. His research interests focus on the development of novel targeted therapeutic strategies for patients with MDS and AML, based on the underlying mutational drivers of each disease. He has authored numerous articles, books, book chapters, and abstracts and serves as reviewer for multiple journals. In 2017, he received the Young Investigator Grant from the MDS Foundation.Â
University of Washington Medical Center, Seattle, Washington, USA
Bart Scott is a medical oncologist at Fred Hutchinson Cancer Research Center in Seattle, Washington. He is Professor of Medicine in the Division of Oncology at the University of Washington Medical Center and Director of Myeloid Malignancies at the Seattle Cancer Center Alliance. He is board certified in internal medicine and medical oncology by the American Board of Internal Medicine. Dr. Scott received his medical degree from the University of Alabama. He then completed his internship and residency at the Johns Hopkins University School of Medicine in Baltimore, Maryland. He completed his fellowship in medical oncology at the University of Washington in Seattle. Dr. Scott has participated in a number of studies involving myelodysplastic syndromes and myeloproliferative disorders. He has published numerous articles in journals such as American Journal of Medicine , Leukemia & Lymphoma , Blood , and Journal of Clinical Oncology . He is also a reviewer for New England Journal of Medicine , British Journal of Haematology , Journal of the National Comprehensive Cancer Network , and Haematologica , among others. Dr. Scott has been an invited lecturer on the management and treatment of myelodysplastic syndromes and transplantation for bone marrow failure. He is a member of the American Medical Association, the American Society of Hematology, the American Society of Clinical Oncology, and the Southwest Oncology Group, among many others.
Hôpital Saint Louis, Paris, France
Pierre Fenaux, is professor of hematology and head of the hematology department at hospitals St Louis, Robert Debré and Avicenne (belonging to Assistance Publique- Hôpitaux de Paris Hospital network). He is also part of Inserm research unit n° 944, at Hôpital St Louis, Paris, for his laboratory research activity Â
He is involved in clinical and laboratory research in the field of myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML, mainly AML in the elderly and acute promyelocytic leukemia, APL ).Â
He is a founding member and chairman of the French speaking MDS group (Groupe Francophone des Myélodysplasies or GFM) and of the French APL group (GT-LAP).
Moffitt Cancer Center, Tampa Florida, USA
Oregon Health & Science University, Portland, Oregon, USA
Moffitt Cancer Center, Tampa Florida, USA
University of Florence, Italy
Moffitt Cancer Center, Tampa Florida, USA
Moffitt Cancer Center, Tampa, Florida, USA
Moffitt Cancer Center, Tampa Florida, USA
University of Washington Medical Center, Seattle, Washington, USA
Moffitt Cancer Center, Tampa Florida, USA
Hospital Saint Louis, Paris, France
